Savara's Series B - II Round

Savara raised a round of funding on March 20, 2013.

Savara (NASDAQ: SVRA) is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare res…

Articles about Savara's Series B - II Round: